Universal Vaginal Applicator for the Uniform Distribution of Vaginal Gel and Cream Formulations: A Magnetic Resonance Imaging Study

Journal of Obstetrics and Gynaecology Canada

Volumn 36, Issue 1, 2014, Pages 42-50

  Omar, Rabeea F ^a   Trottier, Sylvie ^a   Brousseau, Ghislain ^b   Ouellet, Christine ^b   Danylo, Alexis ^a   Ong, Thomas ^b   Bergeron, Michel G ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Distribution; MRI; Vaginal applicator; Vaginal cream; Vaginal gel

Indexed keywords

CLOTRIMAZOLE; METRONIDAZOLE; MICONAZOLE; AGENTS USED INTRAVAGINALLY; TOPICAL ANTIINFECTIVE AGENT;

ABDOMINAL PAIN; ARTICLE; CREAM; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; EQUIPMENT DESIGN; FEMALE; GEL; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN SEVERITY; SPOTTING; UNIVERSAL VAGINAL APPLICATOR; UTERINE CERVIX MUCOSA; VAGINA DISCHARGE; VAGINA MUCOSA; VAGINAL GEL; VULVA PRURITUS; DISTRIBUTION; DRUG EFFECT; EQUIPMENT; INTRAVAGINAL DRUG ADMINISTRATION; UTERINE CERVIX; VAGINA; VAGINAL APPLICATOR; VAGINAL CREAM;

DISTRIBUTION; MRI; VAGINAL APPLICATOR; VAGINAL CREAM; VAGINAL GEL;

ADMINISTRATION, INTRAVAGINAL; ANTI-INFECTIVE AGENTS, LOCAL; CERVIX UTERI; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 84897571062     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30682-4     Document Type: Article

References (17)

1. Lee K. HIV impact-a closing the gap newsletter 2000, Department of Health and Human Services; Spring.
2. Gerbase A.C., Rowley J.T., Mertens T.E. Global epidemiology of sexually transmitted diseases. Lancet 1998, 351(Suppl 3):2-4.
3. Glasier A., Gulmezoglu A., Schmid G., Moreno C., VanLook P. Sexual and reproductive health: a matter of life and death. Lancet 2006, 368:1595-1607.
4. WHO Global prevalence and incidence of selected curable sexually transmitted infections 2007, Overview and estimates. Reference Number: WHO/HIV_AIDS/200102. Available at, Accessed August 31. http://wwwwhoint/hiv/pub/sti/pub7/en/indexhtml.
5. Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 2008, 86(10):805-812. A.
6. UNAIDS Global report 2012- UNAIDS report on the global AIDS epidemic 2012, Available at, Accessed December 14. http://wwwunaidsorg/en/resources/campaigns/20121120_globalreport2012/globalreport.
7. World Health Organization The world health report 2002: reducing risks, promoting healthy life 2004, Available at, Accessed October. http://www.who.int/whr/2002/en.
8. Sidibe M., Piot P., Dybul M. AIDS is not over. Lancet 2012, 380:2058-2060.
9. Fisher W., Boroditsky R., Morris B. The 2002 Canadian contraception study: part 2. J Obstet Gynaecol Can 2004, 26(7):646-656.
10. Lema L., Katapa R., Musa A. Knowledge on HIV/AIDS and sexual behaviour among youths in Kibaha District, Tanzania. Tanzan J Health Res 2008, 10(2):79-83.
11. Omar R.F., Trottier S., Brousseau G., Lamarre A., Gagnon A., Bergeron M.G. Distribution of vaginal gel (Invisible Condom®) before, during and after simulated sexual intercourse and its persistence when delivered by 2 different vaginal applicators - A magnetic resonance imaging (MRI) study. Contraception 2008, 77(6):447-455.
12. Mbopi-Keou F.X., Trottier S., Omar R.F., Nkele N.N., Fokoua S., Mbu E.R., et al. A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women. Contraception 2010, 81(1):79-85.
13. Mbopi-Keou F.-X., Trottier S., Omar R.F., Nkele N.N., Fokoua S., Mbu E.R., et al. A randomized, double-blind, placebo-controlled safety and acceptability study of two the Invisible Condom® formulations in women from Cameroon. Contraception 2009, 80:484-492.
14. Trottier S., Omar R.F., Désormeaux A., Drouin J., Gagnon M.T., Vezina F., et al. Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners. Contraception 2007, 76(2):117-125.
15. Barnhart K., Pretorius E., Stoplen A., Malamud D. Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging. Fertil Steril 2001, 76(1):189-195.
16. Barnhart K.T., Pretorius E.S., Timbers K., Shera D., Shabbout M., Malamud D. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. Contraception 2004, 70(6):498-505.
17. Vail J.G., Cohen J.A., Kelly K.L. Improving topical microbicide applicators for use in resource-poor settings. Am J Public Health 2004, 94(7):1089-1092.